Abstract
This corrigendum serves to correct a typographical error in the reported primary sequence of the synthetic peptide Pa-MAP 1.9, originally described in Scientific Reports (6:21385). The update clarifies that the peptide consists of 28 amino acid residues rather than the 24 residues initially reported. This correction is vital for ensuring the reproducibility of the study's findings regarding the peptide's anti-infectious properties.
Introduction
In the specialized field of peptide engineering and antimicrobial drug discovery, the primary amino acid sequence serves as the essential "source code" for molecular function. Accurate reporting of this sequence is paramount; even a minor omission can lead to failed experimental replications, incorrect structural predictions, and flawed mechanistic models.
The original study, published in February 2016, introduced Pa-MAP 1.9—a polyalanine-rich peptide designed based on structural motifs found in polar fish proteins. While the study detailed the peptide's significant bioactivity against infectious agents, the sequence provided in the Results section was incomplete. This formal correction addresses that discrepancy to maintain the integrity of the scientific record.
The Corrected Sequence
The central update provided by this corrigendum is the addition of four residues to the C-terminus of the Pa-MAP 1.9 peptide.
- Original (Incorrect) Sequence:
NH2-LAAKLTKAATKLTAALTKLAAALT-COOH(24 residues) - Corrected (Actual) Sequence:
NH2-LAAKLTKAATKLTAALTKLAAALTAAAT-COOH(28 residues)
The correction reveals the inclusion of an AAAT (Alanine-Alanine-Alanine-Threonine) motif at the C-terminal end of the molecule.
Significance of the Correction
The transition from a 24-residue to a 28-residue model has significant implications for understanding the peptide's behavior. In polyalanine-based antimicrobial peptides (AMPs), C-terminal extensions are frequently employed to stabilize alpha-helical structures. These helices are often the primary drivers of a peptide's ability to interact with and disrupt the lipid membranes of pathogens.
By providing the full 28-residue sequence, the authors ensure that future researchers can accurately synthesize the molecule and that computational biologists can generate valid structural simulations that align with the experimental bioactivity reported in the original paper.
Conclusion
This corrigendum highlights the importance of scientific transparency and the ongoing process of peer-review and verification. While the fundamental conclusions regarding the peptide's anti-infectious activities remain unchanged, the corrected sequence is the definitive reference for any subsequent work involving Pa-MAP 1.9. Researchers are advised to update their records to reflect the 28-residue sequence: NH2-LAAKLTKAATKLTAALTKLAAALTAAAT-COOH.
Summary updated